0050B |
Acetazolamide, Blood |
0050SP |
Acetazolamide, Serum/Plasma |
0050U |
Acetazolamide, Urine |
0796B |
Bumetanide, Blood |
0796SP |
Bumetanide, Serum/Plasma |
1180B |
Chlorothiazide, Blood |
1180SP |
Chlorothiazide, Serum/Plasma |
1804SP |
Diuretics Panel, Serum/Plasma |
1900B |
Dyazide, Blood |
1900SP |
Dyazide, Serum/Plasma |
2397SP |
Indapamide, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
4207B |
Canrenone (Spironolactone metabolite), Blood |
4207SP |
Canrenone (Spironolactone metabolite), Serum/Plasma |
4275B |
Sumatriptan, Blood |
4275SP |
Sumatriptan, Serum/Plasma |
4275U |
Sumatriptan, Urine |
4525B |
Torsemide, Blood |
4525SP |
Torsemide, Serum/Plasma |
9318U |
Diuretics Screen, Urine |